|
30 May 2016
|
Anuh Pharma
|
Motilal Oswal
|
207.30
|
240.00
|
202.75
(2.24%)
|
Target met |
Buy
|
|
|
In its bid to add new high value products, Anuh has been developing new APIs which have recently gone off patent (post 2014 or which are likely to go off patent in the future). These new APIs will have much higher margins compared to the existing basket. Anuh currently has 20 products in the pipeline of which 4 would be launched in...
|